China Dasheng Biotechnology Company (CDBT)
OTCMKTS · Delayed Price · Currency is USD
0.0316
-0.0274 (-46.44%)
At close: Mar 24, 2025

CDBT Statistics

Total Valuation

CDBT has a market cap or net worth of 2.42 million.

Market Cap 2.42M
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

CDBT has 40.98 million shares outstanding.

Current Share Class n/a
Shares Outstanding 40.98M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

The trailing PE ratio is 0.28.

PE Ratio 0.28
Forward PE n/a
PS Ratio 0.08
PB Ratio 0.09
P/TBV Ratio 0.14
P/FCF Ratio 0.29
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.63, with a Debt / Equity ratio of 0.00.

Current Ratio 6.63
Quick Ratio 6.36
Debt / Equity 0.00
Debt / EBITDA 0.00
Debt / FCF 0.00
Interest Coverage 709.17

Financial Efficiency

Return on equity (ROE) is 39.15% and return on invested capital (ROIC) is 23.49%.

Return on Equity (ROE) 39.15%
Return on Assets (ROA) 19.87%
Return on Invested Capital (ROIC) 23.49%
Return on Capital Employed (ROCE) 29.15%
Revenue Per Employee 30,406
Profits Per Employee 9,298
Employee Count 689
Asset Turnover 0.95
Inventory Turnover 18.30

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +29.51% in the last 52 weeks. The beta is 0.52, so CDBT's price volatility has been lower than the market average.

Beta (5Y) 0.52
52-Week Price Change +29.51%
50-Day Moving Average 0.05
200-Day Moving Average 0.04
Relative Strength Index (RSI) 51.75
Average Volume (20 Days) 11,451

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.00

Income Statement

In the last 12 months, CDBT had revenue of 20.95 million and earned 6.41 million in profits. Earnings per share was 0.21.

Revenue 20.95M
Gross Profit 10.02M
Operating Income 7.04M
Pretax Income 7.33M
Net Income 6.41M
EBITDA 7.72M
EBIT 7.04M
Earnings Per Share (EPS) 0.21
Full Income Statement

Balance Sheet

The company has 10.41 million in cash and 18,134 in debt, giving a net cash position of 10.40 million or 0.25 per share.

Cash & Cash Equivalents 10.41M
Total Debt 18,134
Net Cash 10.40M
Net Cash Per Share 0.25
Equity (Book Value) 22.67M
Book Value Per Share 0.64
Working Capital 12.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.83 million and capital expenditures -1.49 million, giving a free cash flow of 8.34 million.

Operating Cash Flow 9.83M
Capital Expenditures -1.49M
Free Cash Flow 8.34M
FCF Per Share 0.20
Full Cash Flow Statement

Margins

Gross margin is 47.85%, with operating and profit margins of 33.59% and 30.58%.

Gross Margin 47.85%
Operating Margin 33.59%
Pretax Margin 34.97%
Profit Margin 30.58%
EBITDA Margin 36.87%
EBIT Margin 33.59%
FCF Margin 39.79%

Dividends & Yields

CDBT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 6.48%
Shareholder Yield 6.48%
Earnings Yield 264.98%
FCF Yield 344.77%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CDBT has an Altman Z-Score of 8.32.

Altman Z-Score 8.32
Piotroski F-Score n/a